GSA Capital Partners LLP raised its position in Enhabit, Inc. (NYSE:EHAB – Free Report) by 78.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 142,012 shares of the company’s stock after purchasing an additional 62,397 shares during the quarter. GSA Capital Partners LLP owned 0.28% of Enhabit worth $1,122,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Gladius Capital Management LP purchased a new position in Enhabit in the second quarter valued at approximately $31,000. Quarry LP increased its position in shares of Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after acquiring an additional 2,621 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in shares of Enhabit in the 1st quarter valued at $44,000. Stoneridge Investment Partners LLC purchased a new position in shares of Enhabit in the 3rd quarter valued at $81,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Enhabit during the 2nd quarter worth $93,000.
Enhabit Stock Down 2.2 %
Shares of NYSE EHAB opened at $7.44 on Friday. The stock has a fifty day moving average price of $7.58 and a 200 day moving average price of $8.52. The company has a current ratio of 1.46, a quick ratio of 1.48 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $11.74. The company has a market cap of $374.08 million, a P/E ratio of -3.21 and a beta of 1.84.
Insider Activity
In other Enhabit news, Director Jeffrey Bolton bought 5,000 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were bought at an average cost of $8.01 per share, with a total value of $40,050.00. Following the transaction, the director now directly owns 78,877 shares in the company, valued at approximately $631,804.77. This trade represents a 6.77 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.90% of the company’s stock.
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Recommended Stories
- Five stocks we like better than Enhabit
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- 3 Fintech Stocks With Good 2021 Prospects
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Best Stocks Under $10.00
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.